TLDR Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.
The study demonstrated that several naturally occurring compounds, such as hinokitiol, escletin, and quercetin, increased S100A3 citrullination in SW480 cells and promoted cuticular differentiation in isolated human hair follicles. These effects were linked to the inhibition of arachidonate 12-lipoxygenase (ALOX12), which up-regulated heparin-binding epidermal growth factor-like growth factor (HBEGF) and regulated PADI gene expression. Additionally, arachidonic acid promoted S100A3 citrullination and elevated HBEGF in isolated hair follicles, suggesting that ALOX12 inhibition could effectively trigger hair cuticle maturation by modulating arachidonate metabolism in conjunction with HBEGF.
16 citations
,
May 2015 in “Tissue Engineering Part C-methods”
A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.
The post discusses the use of El-Cranell, which contains Alfatradiol, and Quercetin as a treatment for hair loss. The user is seeking recommendations on the amount of Quercetin to add to the solution. The conclusion of the document is that Quercetin has been shown to stimulate hair growth and inhibit DHT, and combining it with zinc/copper may have a synergistic effect.
The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.
Quercetin and houttuynia cordata extract may stimulate hair growth by enhancing cellular energy metabolism and increasing growth factor secretion. Quercetin has low oral bioavailability, and its natural tint might stain the scalp if used topically.
Quercetin might help with hair loss by inhibiting HSP-70, which increases androgen receptors. Concerns include its staining properties and unclear topical absorption.
The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.
